Skip to main content
. 2022 Aug 20;149(7):3739–3752. doi: 10.1007/s00432-022-04184-x

Fig. 5.

Fig. 5

Progression-free survival (PFS) (a) and overall survival (OS) (b) depending on transplant schedule: auto (n = 394), tandem-auto (n = 82) or auto-RICallo-SCT (n = 64). There was no difference in median PFS between auto-RICallo and single/tandem transplanted patients (39 vs 39 months; p = 0.134) and median OS (76 vs 79 months; p = 0.964)